Cholamandalam Financial Holdings Ltd (CHOLAHLDNG) Q1 FY27 Results Analysis: PAT Jumps 39%, Cost-to-Income Improves 332 bps

Cofacto Research Updated August 14, 2026 2 min read
Positive

Cholamandalam Financial Holdings Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 11,113.57 Cr (+19.55% YoY) and PAT growth of +42.04% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 14, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 11,113.57 Cr (+19.55% YoY)
PAT (Q1)Rs. 1,788.99 Cr (+42.04% YoY)
EPS (Q1)Rs. 42.92 (+39.31% YoY)
Market capRs. 30,084.26 Cr
CMPRs. 1,600.00

Quarter Snapshot

Q1 FY27 results show strong operating leverage with PAT growth of 39% YoY, driven by 20% revenue growth and improving credit costs. Disbursements exceeded the guided range, AUM hit the upper end of guidance, and cost-to-income improved 332 bps. Insurance segment remains a drag with low margins. Overall, the NBFC business is executing well with clear momentum.

Key Investment Insights

Key Positives

  • Revenue grew 19.55% YoY to Rs.11,113.57 Cr
  • PAT attributable to owners surged 39.32% YoY to Rs.805.96 Cr
  • CIFCL disbursements grew 22% YoY, above the guided 15-20% range
  • Financing segment PBT grew 45.11% YoY with margin expansion of 402 bps to 25.09%
  • Cost-to-income ratio improved 332 bps YoY to 78.62%
  • Impairment grew only 4.53% YoY, well below revenue growth

Risk Factors

  • Employee benefits expense grew 21.36% YoY, slightly ahead of revenue growth of 19.55%
  • Insurance segment margin contracted slightly from 7.63% to 7.43% and combined ratio likely remains elevated due to lack of TP premium revision
  • CFO change occurred during the quarter (resignation effective 14 June) with a successor appointed same day
Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.

Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings

Login Now